Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy
about
Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Skeletal muscle density is an ...... ximab-based chemoimmunotherapy
@en
Skeletal muscle density is an ...... imab-based chemoimmunotherapy.
@nl
type
label
Skeletal muscle density is an ...... ximab-based chemoimmunotherapy
@en
Skeletal muscle density is an ...... imab-based chemoimmunotherapy.
@nl
prefLabel
Skeletal muscle density is an ...... ximab-based chemoimmunotherapy
@en
Skeletal muscle density is an ...... imab-based chemoimmunotherapy.
@nl
P2093
P2860
P356
P1476
Skeletal muscle density is an ...... ximab-based chemoimmunotherapy
@en
P2093
Amelie Fontaine
Andrew Belch
Jessica Lieffers
Michael B Sawyer
Michael P Chu
Neil S Chua
Randeep Sangha
Robert A Turner
Sunita Ghosh
Vickie E Baracos
P2860
P304
P356
10.1002/JCSM.12161
P577
2016-11-21T00:00:00Z